Mirae Asset Global Investments’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
Other funds holding STOK
GIM
PFSRSONJ
PR
CUAMC
TE
YMRC
VCM
GI
OCWP
Mirae Asset Global Investments's STOK Position: Q2 2026 in Review
Mirae Asset Global Investments reduced its Stoke Therapeutics (STOK) stake by 6.5% in Q2 2026, selling an estimated $6.23K and leaving 2,785 shares worth $91.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1253.
Mirae Asset Global Investments first reported a position in STOK in Q2 2022 and has held it in 14 quarters since. The position peaked at $1.42M in Q2 2023. 20 funds tracked by Wall St. Rank hold STOK as of Q2 2026.
- Mirae Asset Global Investments held 2,785 shares of Stoke Therapeutics worth $91.1K as of Q2 2026.
- Mirae Asset Global Investments sold 194 Stoke Therapeutics shares in Q2 2026, an estimated $6.23K.
- Stoke Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1253 holding.
- Mirae Asset Global Investments first reported a position in Stoke Therapeutics in Q2 2022 and has held it in 14 quarters since.
- Mirae Asset Global Investments's Stoke Therapeutics position peaked at $1.42M in Q2 2023.
- 20 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.
Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.